Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 257
7
Diseases
10
Unique genes
0.330
Avg. similarity score
Arteriovenous hemangioma
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Arteriovenous hemangioma
Blue rubber bleb nevus syndrome
Bockenheimer syndrome
Mucocutaneous venous malformations
TEK-related primary glaucoma
Venous malformation
Congenital venous anomaly
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Arteriovenous hemangioma | 5 | 5 | 4 |
| Blue rubber bleb nevus syndrome | 5 | 5 | 2 |
| Bockenheimer syndrome | 5 | 5 | 1 |
| Mucocutaneous venous malformations | 5 | 5 | 1 |
| TEK-related primary glaucoma | 5 | 5 | 1 |
| Venous malformation | 3 | 3 | 2 |
| Congenital venous anomaly | 2 | 2 | 7 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TEK | 7 / 7 | Arteriovenous hemangioma, Blue rubber bleb nevus syndrome, Bockenheimer syndrome, Congenital venous anomaly and 3 more |
| GLMN | 3 / 7 | Arteriovenous hemangioma, Blue rubber bleb nevus syndrome, Congenital venous anomaly |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Tie2 Signaling | Reactome | 3 / 18 | 200× | 3.37e-7 | 1.90e-5 ✓ sig. |
| Downstream signal transduction | Reactome | 3 / 29 | 124× | 1.50e-6 | 6.93e-5 ✓ sig. |
| Axon guidance | KEGG | 4 / 183 | 26.3× | 1.02e-5 | 3.41e-4 ✓ sig. |
| GnRH secretion | KEGG | 3 / 65 | 55.4× | 1.77e-5 | 5.40e-4 ✓ sig. |
| Signaling by FGFR3 fusions in cancer | Reactome | 2 / 10 | 240× | 2.80e-5 | 7.86e-4 ✓ sig. |
| Ras signaling pathway | KEGG | 4 / 237 | 20.3× | 2.83e-5 | 7.93e-4 ✓ sig. |
| Signaling by FGFR4 in disease | Reactome | 2 / 11 | 218× | 3.42e-5 | 9.32e-4 ✓ sig. |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | Reactome | 2 / 12 | 200× | 4.10e-5 | 1.09e-3 ✓ sig. |
| Signaling by PDGFRA extracellular domain mutants | Reactome | 2 / 12 | 200× | 4.10e-5 | 1.09e-3 ✓ sig. |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | Reactome | 2 / 14 | 172× | 5.65e-5 | 1.41e-3 ✓ sig. |
| VEGFR2 mediated cell proliferation | Reactome | 2 / 14 | 172× | 5.65e-5 | 1.41e-3 ✓ sig. |
| Constitutive Signaling by EGFRvIII | Reactome | 2 / 15 | 160× | 6.51e-5 | 1.58e-3 ✓ sig. |
| Signaling by ERBB2 ECD mutants | Reactome | 2 / 16 | 150× | 7.44e-5 | 1.76e-3 ✓ sig. |
| Cholinergic synapse | KEGG | 3 / 115 | 31.3× | 9.77e-5 | 2.21e-3 ✓ sig. |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | Reactome | 2 / 19 | 126× | 1.06e-4 | 2.36e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| angiogenesis | GO:0001525 | 5 / 284 | 32.9× | 1.85e-7 | 2.03e-5 ✓ sig. |
| vasculogenesis | GO:0001570 | 3 / 63 | 89.0× | 4.31e-6 | 2.66e-4 ✓ sig. |
| positive regulation of Rac protein signal transduction | GO:0035022 | 2 / 18 | 208× | 3.93e-5 | 1.50e-3 ✓ sig. |
| negative regulation of neuron apoptotic process | GO:0043524 | 3 / 160 | 35.0× | 7.07e-5 | 2.34e-3 ✓ sig. |
| regulation of actin filament polymerization | GO:0030833 | 2 / 31 | 121× | 1.19e-4 | 3.45e-3 ✓ sig. |
| sprouting angiogenesis | GO:0002040 | 2 / 37 | 101× | 1.70e-4 | 4.50e-3 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 3 / 217 | 25.8× | 1.75e-4 | 4.59e-3 ✓ sig. |
| regulation of intracellular signal transduction | GO:1902531 | 2 / 40 | 93.4× | 1.99e-4 | 5.03e-3 ✓ sig. |
| ephrin receptor signaling pathway | GO:0048013 | 2 / 51 | 73.3× | 3.24e-4 | 7.07e-3 ✓ sig. |
| heart development | GO:0007507 | 3 / 273 | 20.5× | 3.43e-4 | 7.36e-3 ✓ sig. |
| heart morphogenesis | GO:0003007 | 2 / 61 | 61.3× | 4.64e-4 | 9.10e-3 ✓ sig. |
| cell migration | GO:0016477 | 3 / 303 | 18.5× | 4.65e-4 | 9.12e-3 ✓ sig. |
| integrin biosynthetic process | GO:0045112 | 1 / 1 | 1,869× | 5.35e-4 | 9.98e-3 ✓ sig. |
| regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:1905310 | 1 / 1 | 1,869× | 5.35e-4 | 9.98e-3 ✓ sig. |
| regulation of cell proliferation involved in heart morphogenesis | GO:2000136 | 1 / 1 | 1,869× | 5.35e-4 | 9.98e-3 ✓ sig. |